CopyMark Law Group
4.9
Drawing for CUREPHARMA

USPTO serial 79300671

CUREPHARMA

Reviewed by CopyMark Law Group

Reg. 6648799Status 404
Filing date
Status date
Registration date
Feb 22, 2022
Examiner
SEVERSON, JUSTIN
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with CUREPHARMA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Trademark Monitoring
(312) 319-4460
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Start a new application
(312) 319-4460

Owner

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical substances and preparations for the treatment of neurodegenerative conditions, diseases, and disordersSECTION 70 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 22, 2023DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
Oct 22, 2023DETHDEATH OF INTERNATIONAL REGISTRATION—
Aug 22, 2022FINVFINAL DECISION TRANSACTION PROCESSED BY IB—
Jul 27, 2022XXSSGENERIC MADRID TRANSACTION SENT TO IB—
Jul 27, 2022XXCRGENERIC MADRID TRANSACTION CREATED—
May 22, 2022FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Feb 22, 2022R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 13, 2021GPNXNOTIFICATION PROCESSED BY IB—
Dec 7, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 7, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 17, 2021OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Nov 17, 2021OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Nov 17, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 3, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 5, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 4, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 4, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 6, 2021NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jun 22, 2021ATRVATTORNEY REVIEW COMPLETED—
May 18, 2021CREVCORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED—
May 16, 2021CRCVCORRECTION TRANSACTION RECEIVED FROM IB—
May 3, 2021RFNTREFUSAL PROCESSED BY IB—
Apr 10, 2021RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Apr 10, 2021RFRRREFUSAL PROCESSED BY MPU—
Apr 7, 2021RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Apr 6, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 30, 2021DOCKASSIGNED TO EXAMINER—
Jan 1, 2021MAFRAPPLICATION FILING RECEIPT MAILED—
Dec 28, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 24, 2020REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance